K. N. Verpoort

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

Annette H M van der Helm–van Mil, K. N. Verpoort, Ferdinand C. Breedveld et al. · Arthritis Research & Therapy · 2005 · 474 citations · Full text

The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis

Annette H M van der Helm–van Mil, K. N. Verpoort, Ferdinand C. Breedveld et al. · Arthritis & Rheumatism · 2006 · 348 citations

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

Diane van der Woude, Solbritt Rantapää‐Dahlqvist, A. Ioan-Facsinay et al. · Annals of the Rheumatic Diseases · 2010 · 317 citations

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

K. N. Verpoort, Cornelia M. Jol‐van der Zijde, Ellen A. M. Papendrecht-van der Voort et al. · Arthritis & Rheumatism · 2006 · 210 citations

Association of HLA–DR3 with anti–cyclic citrullinated peptide antibody–negative rheumatoid arthritis

K. N. Verpoort, Floris A. van Gaalen, Annette H M van der Helm–van Mil et al. · Arthritis & Rheumatism · 2005 · 175 citations